What is AlphaClone?
AlphaClone, Inc. is a pioneering financial services firm established in 2008, dedicated to making hedge fund strategies accessible to a broader market. The company's core innovation lies in its proprietary Clone Score methodology, which meticulously replicates the investment tactics of leading hedge fund managers. This approach is embodied in the AlphaClone Alternative Alpha ETF (ALFA), offering retail investors a transparent and cost-effective alternative to traditional, high-fee hedge funds. AlphaClone primarily targets individual investors, including middle-class individuals and emerging traders, who seek to leverage elite investment techniques without prohibitive costs. The firm's commitment to financial inclusion and transparency is central to its mission of broadening access to advanced investment vehicles.
How much funding has AlphaClone raised?
AlphaClone has raised a total of $2.3M across 1 funding round:
Series A
$2.3M
Series A (2015): $2.3M with participation from Operative Capital
Key Investors in AlphaClone
Operative Capital
Operative Capital is an early-stage investor with a specialized focus on disruptive financial technology startups, aligning with AlphaClone's innovative approach to democratizing investment strategies.
What's next for AlphaClone?
The recent major enterprise-level funding indicates a strategic pivot or significant scaling initiative for AlphaClone. This capital infusion is likely to accelerate product development, expand market reach, and enhance the firm's technological infrastructure. With a focus on democratizing hedge fund strategies, AlphaClone is well-positioned to capture a larger share of the retail investment market, potentially driving further innovation in accessible investment products and solidifying its role as a leader in financial inclusion.
See full AlphaClone company page
